Abstract
Troglitazone (TGZ) was the first glitazone used for the treatment of type II diabetes mellitus. TGZ undergoes an oxidative chroman ring-opening reaction to form a quinone product. Recently, cytochrome P450 (P450) was shown to be able to catalyze the formation of TGZ quinone. TGZ quinone was the major metabolite formed by dexamethasone-induced rat liver microsomes or myeloperoxidase (MPO) incubated with TGZ. The ultimate source for the quinone carbonyl oxygen atom of TGZ quinone was investigated using 18O water in both enzyme reaction systems followed by liquid chromatography/tandem mass spectometry analysis of the TGZ quinone product. The resultant TGZ quinone formed by either liver microsomes or MPO contained a single atom of 18O. The 18O atom was determined to be the quinone carbonyl oxygen by collision-induced dissociation fragmentation of the 18O-labeled TGZ quinone. The formation of TGZ quinone was inhibited approximately 90% by coincubation with ascorbic acid or cysteine in the MPO reaction system but only 10 to 20% in liver microsomes, which might reflect the difference in the mechanism by which TGZ quinone is formed by P450 and peroxidase. These results suggest that P450 catalyze an atypical reaction to form TGZ quinone, involving the incorporation of an oxygen from water into the quinone carbonyl position.
Footnotes
-
↵3 Abbreviations used are: TGZ, troglitazone [5-[4-(6-hydroxy-2,5,7,8-tetramethyl-chroman-2-ylmethoxy)-benzyl]-thiazolidine-2,4-dione]; DEX, dexamethasone; MPO, myeloperoxidase; P450, cytochrome P450; RAM, radioactive monitoring; HPLC, high-performance liquid chromatography; LC, liquid chromatography; MS, mass spectometry; CID, collision-induced dissociation.
-
↵1 Current address: DSM-BT, S3216, Wyeth Research, 500 Arcola Road, Collegeville, PA 19426.
-
↵2 Current address: Elan Pharmaceuticals, Inc, 800 Gateway Boulevard, South San Francisco, CA 94080.
- Received July 29, 2003.
- Accepted December 29, 2003.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|